Skip to main content
. 2020 Sep 23;35(1):1712–1726. doi: 10.1080/14756366.2020.1819260

Figure 1.

Figure 1.

Structures of vemurafenib, encorafenib, dabrafenib, sorafenib, and the target compounds.